Results-Approval of Audited Financial Results for the Quarter and Financial Year Ended 31st March, 2026
DHANUKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.4 pts more than Nifty Microcap 250 and 7.2 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dhanuka Agritech reported flat revenue of ₹2,01,979 Lacs for FY26 vs ₹2,03,515 Lacs in FY25, a marginal decline of ~0.8%. PAT fell to ₹28,723 Lacs from ₹29,696 Lacs (~3.3% decline), with basic EPS at ₹63.72 vs ₹65.55 in the prior year. The auditor gave an unmodified opinion with no qualifications. The Board approved a ₹70 crore buyback of up to 5,00,000 equity shares at ₹1,400 per share (1.11% of capital), with promoters intending to participate. A final dividend of ₹2 per share (100% payout) was recommended. The company also announced ESOP 2026 (up to 50,000 options) and SAR Plan 2026 (up to 1,25,000 rights), both pending shareholder approval. New wholly-owned subsidiaries are being set up in Brazil and Europe to manage transferred Bayer brands and register new products internationally. Senior management member Mr. K.B. Kejariwal retired on 31st March 2026.
Revenue and profit both declined marginally year-on-year, likely reflecting challenging agrochemical market conditions. The ₹70 crore buyback and 100% dividend signal confidence, and international expansion via new WOS subsidiaries adds a strategic angle.